Cargando…

The Role of the Automated Implantable Cardioverter Defibrillator (AICD) for Secondary Prevention in the COVID-19 Era

Life-threatening arrhythmias have been variably reported among patients hospitalized for COVID-19 infection. Sudden cardiac arrest (SCA) in COVID-19 patients is an alarming concern for clinicians. Multiple factors play an important role in the development of SCA in patients with severe systemic illn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doodnauth, Andrew V, Zhou, Jordan I, Patel, Krunal H, Yacoub, Fadi, Dunkley, Julian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216574/ https://www.ncbi.nlm.nih.gov/pubmed/34178554 http://dx.doi.org/10.7759/cureus.15783

Ejemplares similares

Reel Syndrome: An Atypical Cause for Inappropriate Shocks in a Patient with Automated Implantable Cardioverter Defibrillator (AICD)
por: Mohammad, Rabia, et al.
Publicado: (2018)

Automated Implantable Cardioverter Defibrillator/Pacemaker Lead Fracture
por: Rubero, Jose, et al.
Publicado: (2020)

Gemella haemolysans: Rare case of automatic implantable cardioverter-defibrillator (AICD) lead infection
por: Kriege, Kevin, et al.
Publicado: (2022)

Stenotrophomonas maltophilia Endocarditis of an Implantable Cardioverter Defibrillator Lead
por: Satish, Mohan, et al.
Publicado: (2019)

Anaesthetic Management of Major Abdominal Oncosurgery in a Patient With an Automated Implantable Cardioverter-Defibrillator (AICD): A Case Report
por: Saini, Heena, et al.
Publicado: (2023)

A Challenging Case of Electrical Storm in an Implantable Cardioverter Defibrillator Patient
por: Elkhouly, Ahmed, et al.
Publicado: (2020)

Inappropriate Subcutaneous Implantable Cardioverter Defibrillator Shocks Secondary to Cardiac Remodeling: A Unique Case of T Wave Oversensing
por: Saleem, Maleeha, et al.
Publicado: (2022)

Effects and Complications of Subcutaneous Implantable Cardioverter-Defibrillator in the Prevention of Sudden Cardiac Death: A Narrative Review
por: Pagore, Prasad A, et al.
Publicado: (2022)

Subcutaneous Implantable Cardioverter-Defibrillator Lead Dislodgement Masquerading as Left Shoulder Pain
por: Chirumamilla, Yashitha, et al.
Publicado: (2023)

Brugada Syndrome: The Role of Risk Stratification in Selecting Patients for Implantable Cardioverter-defibrillator Placement
por: Mankbadi, Michael, et al.
Publicado: (2018)

The subcutaneous implantable cardioverter-defibrillator: A tertiary center experience
por: Khazen, Cesar, et al.
Publicado: (2019)

Refractory Vasospastic Angina and Sudden Cardiac Arrest: Is Implantable Cardioverter Defibrillator Indicated and Is It Always Protective?
por: Riaz, Sana, et al.
Publicado: (2020)

Giant Left Main Coronary Artery Aneurysm Presenting as Multiple Implantable Cardioverter Defibrillator Shocks
por: Malyshev, Yury, et al.
Publicado: (2020)

Inappropriate Shocks With Subcutaneous Implantable Cardioverter-Defibrillator in a Young Patient: A Case Report
por: Khan, Zahid, et al.
Publicado: (2023)

An implantable cardioverter-defibrillator for primary prevention in non-ischemic cardiomyopathy: A systematic review and meta-analysis
por: Wasiak, Michał, et al.
Publicado: (2023)

A Case of 25 Inappropriate Automatic Implantable Cardioverter Defibrillator Shocks and 22 Episodes of Antitachycardia Pacing
por: Morrison, Nathan, et al.
Publicado: (2023)

High-Risk Apical Hypertrophic Cardiomyopathy Requiring an Implantable Cardioverter-Defibrillator: A Case Report of an Overlooked Etiology
por: Rathore, Azeem, et al.
Publicado: (2023)

A Case of Young Brugada Syndrome Patient With Implantable Cardioverter Defibrillator Complication Requiring Device Extraction and Reimplantation
por: Khan, Zahid
Publicado: (2023)

Inappropriate Shock from Subcutaneous Implantable Cardioverter-Defibrillator Caused by Electrical Remodeling After Wolff-Parkinson-White Ablation
por: Mohammadi, Oranus, et al.
Publicado: (2020)

Automatic implantable cardioverter defibrillator (AICD) within the abdomen as a cause of adhesive small bowel obstruction (ASBO): a case report
por: Shean, Christopher J W, et al.
Publicado: (2021)

The Relevance of Preventive Implantable Cardioverter-Defibrillators (ICDs) in Non-Ischemic Cardiomyopathy in the Presence of Effective Quadruple Therapy for Heart Failure: A Review of Contemporary Medical Literature
por: Obi, Mukosolu F, et al.
Publicado: (2023)

Appropriateness of Prescription and Safety of Wearable Cardioverter Defibrillators: A Single-center Experience
por: Sundhu, Murtaza, et al.
Publicado: (2019)

Role of Cardiac Magnetic Resonance (CMR) in Determining Implantable Cardioverter-Defibrillator (ICD) Indication in Acromegalic Cardiomyopathy: A Case Report
por: Inoue, Naoto, et al.
Publicado: (2022)

Secondary prevention implantable cardioverter-defibrillator (ICD) therapy: value in octogenarians
por: Hauck, Christian, et al.
Publicado: (2021)

Comparison and predictors of implantable cardioverter-defibrillator therapy for primary and secondary prevention
por: Evertz, Reinder, et al.
Publicado: (2023)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Implantable Cardioverter-Defibrillator for Primary Prevention in Asia
por: Younis, Arwa, et al.
Publicado: (2023)

Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center
por: Grabowski, Marcin, et al.
Publicado: (2019)

Hyperkalemia Causing Inappropriate Subcutaneous Implantable Cardioverter Defibrillator Shocks in a Patient with End-Stage Renal Disease: A Case Report and Literature Review
por: Botrus, Bachar, et al.
Publicado: (2022)

Acute Saddle Embolus With Thrombus in Transit: A Case Report and Review of the Literature
por: Doodnauth, Andrew V, et al.
Publicado: (2022)

Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator
por: Rahmawati, Anita, et al.
Publicado: (2016)

Subcutaneous implantable cardioverter-defibrillator (S-ICD) for secondary prevention of sudden cardiac death
por: Kempa, Maciej, et al.
Publicado: (2016)

Implantable Cardioverter‐Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review
por: Borne, Ryan T., et al.
Publicado: (2017)

The Abnormal Sinus Rhythm: Myxedema Coma Complicated by Subacute Cardiac Tamponade
por: Chen, Lu, et al.
Publicado: (2021)

A survey study of the use of a subcutaneous implantable cardioverter-defibrillator in various clinical scenarios by expert electrophysiologists in Poland
por: Kempa, Maciej, et al.
Publicado: (2023)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
por: van Barreveld, Marit, et al.
Publicado: (2021)

Pause-prevention pacing in an extravascular implantable cardioverter-defibrillator
por: Sagi, Venkata, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kr7q5tp8sa65gkj6aiiframmsa